ReviewPharmacology & therapeutics2023

Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.

Mélanie A Dacheux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.